Form4insider filings, from the source

Insider · CIK 0001631294

David Renzi

Files at: KALV. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $37k · 1net −$37k
$10k$10k$100k$100k$1M$1MbuyssalesDec 29Dec 29Dec 29Dec 30Dec 30Dec 30Dec 31

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Nov 21, 2016 FMUForm 4 →Nov 23, 1:35 pm ESTKalVista Pharmaceuticals, Inc.CBYL73,280$8.22$602,1120— plan?
Dec 30, 2015 SForm 4 →Dec 31, 4:05 pm ESTCarbylan Therapeutics, Inc.CBYL10,000$3.70$37,0000−100% plan?
Dec 30, 2015 MForm 4 →Dec 31, 4:05 pm ESTCarbylan Therapeutics, Inc.CBYL10,000$0.56$5,60010,000— plan?

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Nov 21, 2016 MForm 4 →Nov 23, 1:35 pm ESTKalVista Pharmaceuticals, Inc.CBYL36,640——0—
Jan 4, 2016 AForm 4 →Jan 5, 4:06 pm ESTCarbylan Therapeutics, Inc.CBYL283,000——283,000—
Dec 30, 2015 MForm 4 →Dec 31, 4:05 pm ESTCarbylan Therapeutics, Inc.CBYL10,000——515,825—
Aug 3, 2015 AForm 4 →Aug 5, 4:27 pm EDTCarbylan Therapeutics, Inc.CBYL276,506——276,506—